// App-Quantinova.ai

Mo1480 : Adding Alpha-Fetoprotein to Ultrasound in Hepatocellular Carcinoma Screening Leads to High Rates of Over-Investigation With Few Additional Diagnoses

Researchers

Presenter

  • Nina Parthasarathy

Principal Investigators

  • Abhinav Vasudevan

  • Desmond Patrick

  • John Lubel

  • Amanda Nicoll

Medical Centers

  • Deakin University, Melbourne, Australia

  • Gastroenterology and Hepatology, Western Hospital, Melbourne, Victoria, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Alpha-fetoprotein

Drug/Treatment

  • Alfa-fetoprotein

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved